如何用红细胞输注和铁剂治疗贫血
本文讨论严重贫血的红细胞输注策略与铁剂治疗。临床试验显示限制性输注策略(7至8 g/dL)在多种临床场景与宽松策略(9至10 g/dL)同样安全,但冠心病、急性心肌梗死、充血性心力衰竭和骨髓增生异常肿瘤等亚组缺乏证据。文章通过3个临床案例说明输注应结合症状、患者偏好和血红蛋白浓度,并强调评估贫血病因,静脉铁剂通常为复杂内科疾病绝对性缺铁的治疗选择。
要点
- 限制性输血策略(7至8 g/dL)在多种临床场景与宽松策略(9至10 g/dL)同样安全。
- 冠心病、急性心肌梗死、充血性心力衰竭和骨髓增生异常肿瘤等亚组缺乏证据。
- 复杂内科疾病绝对性缺铁通常选择静脉铁剂治疗,可伴或不伴功能性缺铁。
核心结论
- 输血实践应结合患者症状、偏好和血红蛋白浓度进行指导。
- 在决定输血的同时,评估和管理贫血病因至关重要。
- 复杂内科疾病患者的绝对性缺铁通常选择静脉铁剂治疗,伴或不伴功能性缺铁。
主要发现
- 临床试验显示限制性输血策略7至8 g/dL在多种临床场景与宽松策略9至10 g/dL同样安全。
- 冠心病、急性心肌梗死、充血性心力衰竭和骨髓增生异常肿瘤等亚组患者缺乏证据。
- 铁限制性红细胞生成是贫血严重到考虑红细胞输注的常见原因。
- 绝对性缺铁性贫血、伴功能性缺铁的炎症性贫血或两者并存的诊断和管理可能存在问题。
临床怎么用
- 输血实践应结合患者症状、偏好和血红蛋白浓度进行指导。
- 决定输血的同时应评估和管理贫血病因。
- 复杂内科疾病患者的绝对性缺铁通常选择静脉铁剂治疗,伴或不伴功能性缺铁。
局限性
- 冠心病、急性心肌梗死、充血性心力衰竭和骨髓增生异常肿瘤等亚组患者缺乏证据。
- 绝对性缺铁性贫血、伴功能性缺铁的炎症性贫血或两者并存的诊断和管理可能存在问题。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Severe anemia is commonly treated with red blood cell transfusion. Clinical trials have demonstrated that a restrictive transfusion strategy of 7 to 8 g/dL is as safe as a liberal transfusion strategy of 9 to 10 g/dL in many clinical settings. Evidence is lacking for subgroups of patients, including those with preexisting coronary artery disease, acute myocardial infarction, congestive heart failure, and myelodysplastic neoplasms. We present 3 clinical vignettes that highlight the clinical challenges in caring for patients with coronary artery disease with gastrointestinal bleeding, congestive heart failure, or myelodysplastic neoplasms. We emphasize that transfusion practice should be guided by patient symptoms and preferences in conjunction with the patient's hemoglobin concentration. Along with the transfusion decision, evaluation and management of the etiology of the anemia is essential. Iron-restricted erythropoiesis is a common cause of anemia severe enough to be considered for red blood cell transfusion but diagnosis and management of absolute iron deficiency anemia, the anemia of inflammation with functional iron deficiency, or their combination may be problematic. Intravenous iron therapy is generally the treatment of choice for absolute iron deficiency in patients with complex medical disorders, with or without coexisting functional iron deficiency.
引用
- Carson JL, Brittenham GM. How I treat anemia with red blood cell transfusion and iron. Blood. 2023. PMID: 36315909. doi:10.1182/blood.2022018521
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。